Prognostic value of TP53, KRAS and EGFR mutations in nonsmall cell lung cancer:The EUELC cohort
| Data(s) |
01/07/2012
|
|---|---|
| Resumo |
Nonsmall cell lung cancer samples from the European Early Lung Cancer biobank were analysed to assess the prognostic significance of mutations in the TP53, KRAS and EGFR genes. The series included 11 never-smokers, 86 former smokers, 152 current smokers and one patient without informed smoking status. There were 110 squamous cell carcinomas (SCCs), 133 adenocarcinomas (ADCs) and seven large cell carcinomas or mixed histologies. Expression of p53 was analysed by immunohistochemistry. DNA was extracted from frozen tumour tissues. TP53 mutations were detected in 48.8% of cases and were more frequent among SCCs than ADCs (p |
| Identificador |
http://dx.doi.org/10.1183/09031936.00097311 http://www.scopus.com/inward/record.url?eid=2-s2.0-84863486249&partnerID=8YFLogxK |
| Idioma(s) |
eng |
| Direitos |
info:eu-repo/semantics/restrictedAccess |
| Fonte |
Scoccianti , C , Martel , G , Olivier , M , Hainaut , P , Vesin , A , Brambilla , E , Timsit , J-F , Brambilla , C , Field , J K , Tavecchio , L , Martinet , Y , Thunnissen , E , Snijders , P , Sozzi , G , Risch , A , Elborn , S , Montuenga , L M , O'Byrne , K , Harrison , D J & Niklinski , J 2012 , ' Prognostic value of TP53, KRAS and EGFR mutations in nonsmall cell lung cancer : The EUELC cohort ' European Respiratory Journal , vol 40 , no. 1 , pp. 177-184 . DOI: 10.1183/09031936.00097311 |
| Tipo |
article |
